Lupin Ltd has informed BSE regarding a Press Release dated April 26, 2013 titled "Lupin receives FDA approval for its Oral Contraceptive Pirmella 7/7/7 and Pirmella 1/35 Tablets".
Lupin subsidiary, Lupin Pharma received final approval for its oral contraceptive Pirmella 7/7/7 and Pirmella 1/35 tablets from USFDA to market a generic version of Janssen Pharmaceuticals Inc
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!